Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive Headaches (NCT04685772) | Clinical Trial Compass
RecruitingNot Applicable
Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive Headaches
United States25 participantsStarted 2021-04-01
Plain-language summary
This novel pilot project will assess the effectiveness of corticosteroids in treatment of acute post-concussion headache. The investigators hypothesize that the use of corticosteroids will cause significant headache reduction in frequency and/or intensity than individuals who undergo the current standard of care. Additionally, the investigators hypothesize that corticosteroid use will lead to a reduction in other somatic symptoms including vestibular symptoms, leading to quicker return to school, work, and/or ability to play sports.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Provision of signed and dated informed consent form (in person or via telehealth)
✓. Stated willingness to comply with all study procedures and availability for the duration of the study
✓. Male or female, aged \>18 years old
✓. Ability to take oral medication and be willing to adhere to the study regimen as described in this protocol
✓. Patients presenting with all types of post-concussive headache with \>5/10 in severity on the numerical analog scale.
✓. Headache that occurs for \> 4 hours per day
✓. Headache that occurs every day
✓. Headache that began after concussion, patient was diagnosed at an outpatient clinic or was hospitalized
Exclusion criteria
✕. Any evidence of known intracranial hemorrhage on neuroimaging
✕. Headache developing after 7 days post injury and patient presenting after 30 days from initial trauma